Khallouf, H., Märten, A., Serba, S., Teichgräber, V., Büchler, M. W., Jäger, D., & Schmidt, J. (2012). 5-fluorouracil and interferon-α immunochemotherapy enhances immunogenicity of murine pancreatic cancer through upregulation of NKG2D ligands and MHC class I. Journal of immunotherapy, 35(3), . https://doi.org/10.1097/CJI.0b013e31824b3a76
Chicago-Zitierstil (17. Ausg.)Khallouf, Hadeel, Angela Märten, Susanne Serba, Volker Teichgräber, Markus W. Büchler, Dirk Jäger, und Jan Schmidt. "5-fluorouracil and Interferon-α Immunochemotherapy Enhances Immunogenicity of Murine Pancreatic Cancer Through Upregulation of NKG2D Ligands and MHC Class I." Journal of Immunotherapy 35, no. 3 (2012). https://doi.org/10.1097/CJI.0b013e31824b3a76.
MLA-Zitierstil (9. Ausg.)Khallouf, Hadeel, et al. "5-fluorouracil and Interferon-α Immunochemotherapy Enhances Immunogenicity of Murine Pancreatic Cancer Through Upregulation of NKG2D Ligands and MHC Class I." Journal of Immunotherapy, vol. 35, no. 3, 2012, https://doi.org/10.1097/CJI.0b013e31824b3a76.